Active Stocks

Fri Sep 22 2023 15:58:38

Tata Steel share price
126.7 -0.86%

HDFC Bank share price
1,529.2 -1.57%

State Bank Of India share price
598.1 1.67%

Power Grid Corporation Of India share price
199.1 -1.34%

Tata Motors share price
621.1 -0.93%

Business News > Mint Authors > Leroy Leo

Leroy Leo

Mint Author

ARTICLES BY LEROY LEO

If concluded, the deal would give Sanofi close to 4.6% of the world’s consumer healthcare market, making it the global leader in the segment. Photo: AFP

Sanofi to let go of staff at vaccine plants in India as part of review

1 min read . 30 Jan 2023

The lower COVID-19 disease severity during the Omicron period is likely related to higher vaccination coverage, booster use among those eligible for the extra shots, as well as prior infections providing some immune protection, the study said. (AFP)

Covid-19 is less severe with Omicron than Delta, suggests US study

1 min read . 26 Jan 2022

The price of these shots range between ₹1,500 and ₹2,000 (AP)

Demand for flu vaccine rises in India as covid raises awareness

1 min read . 24 Nov 2021

Merck said the US government has the right to buy 2 million more courses as part of the contract

US govt to buy another $1 bn worth of Merck's Covid-19 pill

1 min read . 09 Nov 2021

An authorization from the US Food and Drug Administration could help change clinical management of COVID-19 as the pill can be taken at home. (Photo:' Reuters)

Merck seeks first US authorization for Covid-19 tablet

1 min read . 11 Oct 2021

As per the order, the NPPA has used its emergency powers under paragraph 19 of the Drug Price Control Order to cap the margins paid to distributors in a bid to lower the prices of pulse oximeter, blood pressure monitoring machine, nebulizer, digital thermometer and glucometer. (REUTERS)

NPPA caps trade margins of pulse oximeter, digital thermometer at 70%

1 min read . 14 Jul 2021

For RDIF, the global commercialising partner for the Russian vaccine Sputnik V, Serum Institute becomes the seventh contract manufacturer in India after Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech and Morepen Laboratories. (Reuters)

SII to produce 300 million doses of Sputnik V jabs annually

2 min read . 14 Jul 2021

Sanofi and GSK had already started recruiting participants for the phase 3 trial in the US in late May and have plans to initiate the process in several countries in Asia, Africa and Latin America in the coming weeks. (AFP)

Sanofi, GSK get nod for phase 3 trial of covid-19 vaccine in India

1 min read . 08 Jul 2021

French pharmaceutical giant Sanofi aims to prevent covid in unvaccinated adults who have not been infected earlier.ap

Sanofi seeks nod to conduct phase 3 trial of its jab in India

2 min read . 07 Jul 2021

Brazil suspends $320 million deal with Bharat Biotech for Covaxin

1 min read . 30 Jun 2021

Bharat Biotech’s pricing strategy in India has also become controversial as its CMD Krishna Ella in August last year said that the jab would cost less than a bottle of water, but is now pricing its doses at as much as Rs1,200 per dose for private hospitals. (REUTERS)

Brazil suspends contract to buy 20 mn doses of Bharat Biotech’s Covaxin

2 min read . 30 Jun 2021

India is one of more than 50 countries where Moderna’s jab has been allowed.

Moderna’s vaccine gets emergency use nod, India partner Cipla to import jabs

3 min read . 30 Jun 2021

Cipla gets authorisation for restricted use in India of donated Moderna vaccines. (File photo)

Cipla gets authorisation for restricted use in India of donated Moderna vaccines

1 min read . 29 Jun 2021

Adar Poonawalla, chief executive officer of Serum Institute of India. (Photo: Mint)

Serum Institute applies for emergency use licence for Covishield in EU

2 min read . 29 Jun 2021

MSD India managing director Rehan A. Khan.

MSD in talks to give additional licences for molnupiravir

2 min read . 27 Jun 2021

Thyrocare chairman A. Velumani will acquire a stake of less than 5% in API Holdings Ltd as part of a series of equity investments by existing and new investors of API. Photo: Mint

PharmEasy buys 66% stake in Thyrocare

2 min read . 26 Jun 2021

CoWin head R.S. Sharma says international travellers should give passport as ID proof. (Photo: Mint)

Need to work with countries on vax passport: R.S. Sharma

4 min read . 25 Jun 2021

CoWin head R.S. Sharma says international travellers should give passport as ID proof. (Photo: Mint)

Need to work with countries on vax passport: R.S. Sharma

4 min read . 25 Jun 2021

Bharat Biotech is yet to publish detailed phase 3 efficacy data for Covaxin

Covaxin shows 77.8% efficacy a day before the company meets WHO officials

2 min read . 23 Jun 2021

Union Health Secretary Rajesh Bhushan.

Govt alerts three states about ‘delta plus’ variant

2 min read . 22 Jun 2021